Verrica Pharmaceuticals Inc.
NASDAQ:VRCA
Overview | Financials
Company Name | Verrica Pharmaceuticals Inc. |
Symbol | VRCA |
Currency | USD |
Price | 0.83 |
Market Cap | 37,844,100 |
Dividend Yield | 0% |
52-week-range | 0.704 - 11.41 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Ted White |
Website | https://www.verrica.com |
An error occurred while fetching data.
About Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and which is
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD